You just read:

Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)

News provided by

Valeant Pharmaceuticals International, Inc.

May 27, 2015, 05:59 ET